Advanced search
1 file | 254.41 KB

Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy

(2010) JOURNAL OF CLINICAL ONCOLOGY. 28(23). p.3687-3694
Author
Organization
Keywords
RADIATION-THERAPY SIRT, 1ST-LINE TREATMENT, RANDOMIZED-TRIAL, METABOLIC-RESPONSE, PLUS IRINOTECAN, LEUCOVORIN, SUPPORTIVE CARE, PET, TUMORS, CETUXIMAB

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 254.41 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Hendlisz, Alain, Marc Van den Eynde, Marc Peeters, Geert Maleux, Bieke Lambert, Jaarke Vannoote, Katrien De Keukeleire, et al. 2010. “Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or with Yttrium-90 Resin Microspheres Radioembolization for Liver-limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy.” Journal of Clinical Oncology 28 (23): 3687–3694.
APA
Hendlisz, Alain, Van den Eynde, M., Peeters, M., Maleux, G., Lambert, B., Vannoote, J., De Keukeleire, K., et al. (2010). Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. JOURNAL OF CLINICAL ONCOLOGY, 28(23), 3687–3694.
Vancouver
1.
Hendlisz A, Van den Eynde M, Peeters M, Maleux G, Lambert B, Vannoote J, et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2010;28(23):3687–94.
MLA
Hendlisz, Alain, Marc Van den Eynde, Marc Peeters, et al. “Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or with Yttrium-90 Resin Microspheres Radioembolization for Liver-limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy.” JOURNAL OF CLINICAL ONCOLOGY 28.23 (2010): 3687–3694. Print.
@article{1193749,
  author       = {Hendlisz, Alain and Van den Eynde, Marc and Peeters, Marc and Maleux, Geert and Lambert, Bieke and Vannoote, Jaarke and De Keukeleire, Katrien and Verslype, Chris and Defreyne, Luc and Van Cutsem, Eric and Delatte, Philippe and Delaunoit, Thierry and Personeni, Nicola and Paesmans, Marianne and Van Laethem, Jean-Luc and Flamen, Patrick},
  issn         = {0732-183X},
  journal      = {JOURNAL OF CLINICAL ONCOLOGY},
  keyword      = {RADIATION-THERAPY SIRT,1ST-LINE TREATMENT,RANDOMIZED-TRIAL,METABOLIC-RESPONSE,PLUS IRINOTECAN,LEUCOVORIN,SUPPORTIVE CARE,PET,TUMORS,CETUXIMAB},
  language     = {eng},
  number       = {23},
  pages        = {3687--3694},
  title        = {Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy},
  url          = {http://dx.doi.org/10.1200/JCO.2010.28.5643},
  volume       = {28},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: